Showing results (761-770 of 1,402) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|December 15, 2018
Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeysEriko Suzuki, Naoko Nishimura, Tetsuya Yoshikawa, et al.Pharmacology Research & Perspectives|January 6, 2022
Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancerAseel K AbuSara, Deema H Abdelrahman, Khader I Habash, et al.Pharmacology Research & Perspectives|March 16, 2021
Side-effects of carbetocin to prevent postpartum hemorrhage: A systematic review and meta-analysis of randomized controlled trialsWen Ai, Yanfei Zeng, Yubo Ma, et al.Pharmacology Research & Perspectives|March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progressionAmlan Das, Inamul Haque, Priyanka Ray, et al.Pharmacology Research & Perspectives|March 22, 2021
In vitro cytochrome P450- and transporter-mediated drug interaction potential of 6β-hydroxy-21-desacetyl deflazacort-A major human metabolite of deflazacortJiyuan Ma, Brian Beers, Ravi Manohar, et al.Pharmacology Research & Perspectives|September 7, 2022
Comparison of 24-hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney diseaseEsben Iversen, Lene Boesby, Ditte Hansen, et al.Pharmacology Research & Perspectives|September 1, 2022
Toward a big picture of COVID-19Felix Tretter, Janet J McIntyre-Mills, Gary R SmithPharmacology Research & Perspectives|August 2, 2019
Therapeutic potential of adenosine kinase inhibition-RevisitedMichael F JarvisPharmacology Research & Perspectives|February 7, 2021
Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditionsRay J Li, Gillian E Caughey, Sepehr ShakibPharmacology Research & Perspectives|January 15, 2021
Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in ratsJing Zheng, Manyun Long, Zhenbai Qin, et al.Pageof 141